T-cell large granular lymphocytic (T-LGL) leukemia: Experience in a single institution over 8 years

Leukemia Research

Volumn 31, Issue 7, 2007, Pages 939-945

  Aribi, Ahmed ^a   Huh, Yang ^a   Keating, Michael ^a   O'Brien, Susan ^a   Ferrajoli, Alessandra ^a   Faderl, Stefan ^a   Wierda, William ^a   Kantarjian, Hagop ^a   Ravandi, Farhad ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cyclosporine; Immunomodulation therapy; T cell large granular lymphocyte leukemia

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ERYTHROPOIETIN; FLUDARABINE; METHOTREXATE; PENTOSTATIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOPENIA; FEMALE; HUMAN; LARGE GRANULAR LYMPHOCYTE; LEUKEMIA REMISSION; LYMPHATIC LEUKEMIA; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; SPLENECTOMY; T CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; CYCLOSPORINE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, T-CELL; MALE; MIDDLE AGED; PENTOSTATIN; RETROSPECTIVE STUDIES; VIDARABINE;

EID: 34249814921     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.09.003     Document Type: Article

References (35)

1. Ravandi F., Kantarjian H., Jones D., Dearden C., Keating M., and O'Brien S. Mature T-cell leukemias. Cancer 104 (2005) 1808-1818
2. Ravandi F., and O'Brien S. Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatment. Mayo Clin Proc 80 (2005) 1660-1674
3. Loughran Jr. T.P. Clonal diseases of large granular lymphocytes. Blood 82 (1993) 1-14
4. Loughran Jr. T.P., and Starkebaum G. Clinical features in large granular lymphocytic leukaemia. Blood 69 (1987) 1786
5. Semenzato G., Pandolfi F., Chisesi T., et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 60 (1987) 2971-2978
6. Oshimi K. Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature. Leukemia 2 (1988) 617-627
7. Lamy T., and Loughran Jr. T.P. Clinical features of large granular lymphocyte leukemia. Semin Hematol 40 (2003) 185
8. Perzova R., and Loughran Jr. T.P. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol 97 (1997) 123-126
9. Oshimi K., Shinkai Y., Okumura K., Oshimi Y., and Mizoguchi H. Perforin gene expression in granular lymphocyte proliferative disorders. Blood 75 (1990) 704-708
10. Kothapalli R., Bailey R.D., Kusmartseva I., Mane S., Epling-Burnette P.K., and Loughran Jr. T.P. Constitutive expression of cytotoxic proteases and down regulation of protease inhibitors in LGL leukemia. Int J Oncol 22 (2003) 33-39
11. Loughran Jr. T.P., Coyle T., Sherman M.P., et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 80 (1992) 1116-1119
12. Loughran Jr. T.P., Hadlock K.G., Perzova R., et al. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 101 (1998) 318-324
13. Greer J.P., Kinney M.C., and Loughran Jr. T.P. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program) (2001) 259-281
14. Liu J.H., Wei S., Lamy T., et al. Chronic neutropenia mediated by fas ligand. Blood 95 (2000) 3219-3222
15. Chan W.C., Catovsky D., Foucar K., and Montserrat E. T-cell large granular lymphocyte leukemia. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours: tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France 197-198
16. Semenzato G., Zambello R., Starkebaum G., Oshimi K., and Loughran Jr. T.P. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89 (1997) 256-260
17. Saunthahararajah Y., Molldrem J.L., Rivera M., et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 112 (2001) 195-200
18. Cheson B.D., Bennett J.M., Kantarjian H., et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 96 (2000) 3671-3674
19. Rose M.G., and Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 9 (2004) 247-258
20. Takeuchi M., Tamaoki A., Soda R., and Takahashi K. Spontaneous remission of large granular lymphocyte T cell leukemia. Leukemia 13 (1999) 313-314
21. Dhodapkar M.V., Li C.Y., Lust J.A., Tefferi A., and Phyliky R.L. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 84 (1994) 1620-1627
22. Osuji N., Matutes E., Wotherspoon A., and Catovsky D. Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatment. Leuk Res 29 2 (2005) 225-228
23. Loughran Jr. T.P., Kidd P.G., and Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 84 (1994) 2164-2170
24. Sood R., Stewart C.C., Aplan P.D., et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 91 (1998) 3372-3378
25. Go R.S., Li C.Y., Tefferi A., and Phyliky R.L. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 98 (2001) 483-485
26. Battiwalla M., Melenhorst J., Saunthararajah Y., et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 123 3 (2003 Nov) 449-453
27. Sternberg A., Eagleton H., Pillai N., Leyden K., Turner S., Pearson D., et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol 120 (2003) 699-701
28. Brinkman K., van Dongen J.J., van Lom K., Groeneveld K., Misere J.F., and van derHeul C. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies. Leukemia 12 (1998) 150-154
29. Pastor E., and Sayas M.J. Severe neutropenia associated with large granular lymphocyte lymphocytosis: successful control with cyclosporin A. Blut 59 (1989) 501-502
30. Hamidou M.A., Sadr F.B., Lamy T., et al. Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. Am J Med 108 9 (2000) 730-732
31. Osuji N., Matutes E., Tjonnfjord G., et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer 107 3 (2006) 570-578
32. Ru X., and leibman H.A. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol 123 (2003) 278-281
33. Rosenblum M.D., LaBelle J.L., Chang C.C., Margolis D.A., Schauer D.W., and Vesole D.H. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukaemia. Blood 103 (2004) 1969-1971
34. Osuji N., Del Giudice I., Matutes E., Morilla A., Owusu-Ankomah K., Morilla R., et al. CD52 expression in T-cell large granular lymphocyte leukaemia-implications for treatment with alemtuzumab. Leuk Lymphoma 46 (2005) 723-727
35. Wachi K., Prasertsuntarasai T., Kishimoto M., and Uramoto K. T-cell lymphopenia associated with infliximab and cyclophosphamide. Am J Med Sci 330 (2005) 48-51